7月14日，Intellia Therapeutics盘中下跌9.74%，报12.83美元/股，成交额6898.69万美元。
Intellia Therapeutics所在的生物科技行业中，个股中，艾吉纳斯公司涨90.9%，Q32 Bio Inc.涨77.25%，艾伯维公司跌0.36%，阿尔尼拉姆制药公司跌4.22%，Moderna, Inc.跌1.96%。
Intellia Therapeutics是一家基因编辑公司，专注于利用CRISPR/Cas9系统开发潜在治愈性疗法。公司核心产品Lonvo-Z此前在遗传性血管水肿三期临床试验中取得积极结果，已启动向FDA的滚动BLA提交，预计有望于明年上半年在美国上市。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.